| pubmed-article:14500110 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14500110 | lifeskim:mentions | umls-concept:C0013987 | lld:lifeskim |
| pubmed-article:14500110 | lifeskim:mentions | umls-concept:C0030971 | lld:lifeskim |
| pubmed-article:14500110 | lifeskim:mentions | umls-concept:C0015413 | lld:lifeskim |
| pubmed-article:14500110 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:14500110 | lifeskim:mentions | umls-concept:C0018546 | lld:lifeskim |
| pubmed-article:14500110 | lifeskim:mentions | umls-concept:C0073393 | lld:lifeskim |
| pubmed-article:14500110 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:14500110 | lifeskim:mentions | umls-concept:C1280519 | lld:lifeskim |
| pubmed-article:14500110 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:14500110 | pubmed:dateCreated | 2003-9-22 | lld:pubmed |
| pubmed-article:14500110 | pubmed:abstractText | We used a psychophysiological marker of visual attention (the visual scanpath) to investigate the effects of atypical (risperidone) vs. typical (haloperidol) antipsychotic medication on facial emotion perception in schizophrenia (n=28) and healthy control (n=28) groups. Of the schizophrenia subjects, 15 were prescribed risperidone. Visual scanpaths to 'happy', 'sad' and 'neutral' faces were recorded using video-oculography, and concurrent emotion-recognition accuracy was assessed using multiple-option tasks. Compared to control subjects, both schizophrenia subgroups showed a restriction in visual scanning (reduced total fixation number and decreased scanpath length). Haloperidol-treated schizophrenia subjects exhibited an additional and consistent pattern of reduced attention (fixation) to salient features for neutral and happy. By contrast, risperidone-treated subjects showed a relatively greater attention to salient features for these expressions, in which they did not differ from controls. Recognition accuracy for happy and neutral showed a similar lack of impairment. These findings suggest that risperidone may play a specific role in schizophrenia in the ability to attend to salient features, and to integrate this information into an accurate percept for neutral and positive expressions in particular. | lld:pubmed |
| pubmed-article:14500110 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14500110 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14500110 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14500110 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14500110 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14500110 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14500110 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14500110 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:14500110 | pubmed:issn | 0165-1781 | lld:pubmed |
| pubmed-article:14500110 | pubmed:author | pubmed-author:GordonEvianE | lld:pubmed |
| pubmed-article:14500110 | pubmed:author | pubmed-author:LoughlandCarm... | lld:pubmed |
| pubmed-article:14500110 | pubmed:author | pubmed-author:WilliamsLeann... | lld:pubmed |
| pubmed-article:14500110 | pubmed:author | pubmed-author:HarrisAnthony... | lld:pubmed |
| pubmed-article:14500110 | pubmed:author | pubmed-author:GreenMelissa... | lld:pubmed |
| pubmed-article:14500110 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14500110 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:14500110 | pubmed:volume | 120 | lld:pubmed |
| pubmed-article:14500110 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14500110 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14500110 | pubmed:pagination | 13-27 | lld:pubmed |
| pubmed-article:14500110 | pubmed:dateRevised | 2008-4-17 | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:meshHeading | pubmed-meshheading:14500110... | lld:pubmed |
| pubmed-article:14500110 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14500110 | pubmed:articleTitle | Emotion perception in schizophrenia: an eye movement study comparing the effectiveness of risperidone vs. haloperidol. | lld:pubmed |
| pubmed-article:14500110 | pubmed:affiliation | School of Psychology, University of Sydney, Sydney, NSW 2006, Australia. lea@psych.usyd.edu.au | lld:pubmed |
| pubmed-article:14500110 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14500110 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:14500110 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:14500110 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:14500110 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14500110 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14500110 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14500110 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14500110 | lld:pubmed |
